NCT02873104已完成不适用
Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction
Cutera Inc.2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2016年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 70
- 试验地点
- 2
- 主要终点
- Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment
研究概览
简要总结
To evaluate the safety and efficacy of the Cutera truSculpt radiofrequency device for circumferential reduction.
详细描述
The objectives of this study are to evaluate efficacy and safety of treatment with the Cutera truSculpt RF device for circumferential reduction in the abdominal and flank region.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 24 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Female or Male, 24 to 60 years of age (inclusive). Fitzpatrick Skin Type I - VI. Has visible fat bulges on the abdomen and palpable fat pockets superior to iliac crest located bilaterally in the lower back flank region Has a Body Mass Index (BMI) ≥ 20 and ≤ 30 Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.
- •Subject must agree to not undergo any other procedure(s) in the abdominal and flank region during the study period.
- •Subject must be able to read, understand and sign the Informed Consent Form. Subject must adhere to the follow-up schedule and study instructions. Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study, within 5% of baseline weight measurement.
- •Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, educational or marketing purposes.
- •Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant.
排除标准
- •Participation in a clinical trial of another device or drug within 6 months of study participation, or during the study period.
- •Any type of prior cosmetic treatment to the target area within 12 months of study participation e.g., radiofrequency, cryolysis or light-based treatments.
- •Any prior invasive cosmetic surgery to the target area, such as liposuction. Currently taking medications or supplements for weight-loss or metabolism support/enhancement or has a history of taking such medications or supplements within 3 months.
- •Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.
- •Has metal implant(s) within the body, such as surgical clips, plates and screws, intrauterine device (IUD), artificial heart valves or artificial joints.
- •Significant concurrent illness, such as diabetes mellitus, cardiovascular disease, peripheral vascular disease or pertinent neurological disorders.
- •Diagnosed or documented immune system disorders. History of any disease or condition that could impair wound healing. History of diseases stimulated by heat, such as recurrent herpes zoster in the treatment area, unless treatment is conducted following a prophylactic regimen.
- •History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.
- •Infection, dermatitis, rash or other skin abnormality in the target area. Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.
- •Pregnant or currently breastfeeding. As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
结局指标
主要结局
Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment
时间窗: 12 weeks
Change in Abdominal Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment minus Baseline Measurement
次要结局
- Subject Assessment of Improvement for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.(12 weeks)
- Subject Satisfaction Level for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.(12 weeks)
- Subject Discomfort and Pain Levels During Treatment(12 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
The Trusculpt (Radio Frequency) Device For Thigh Circumference ReductionBody FatNCT01665118Cutera Inc.44
终止
不适用
Thigh Circumference Reduction StudyReduction of Localized Excess FatNCT00953290Cutera Inc.4
已完成
不适用
Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential ReductionAbdominal FatNCT03428243Cutera Inc.14
Unknown
2 期
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal WandHSIL, High Grade Squamous Intraepithelial LesionsHPV-Related Squamous Cell CarcinomaHuman Papilloma VirusAin IIIAnal CancerHuman Papillomavirus InfectionNCT03302858Stephen E. Goldstone70
已完成
不适用
Multi-Center Pilot Study of Cutera truSculpt DeviceTreatment for Cellulite on the Stomach and FlanksNCT03782545Cutera Inc.34